# Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

> **NCT00467844** · PHASE2 · COMPLETED · sponsor: **GTx** · enrollment: 159 (actual)

## Conditions studied

- Cachexia

## Interventions

- **DRUG:** GTx-024
- **DRUG:** GTx-024
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00467844
- **Lead sponsor:** GTx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2014-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00467844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00467844, "Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00467844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*